Victoria Meucci Villaflor

Associate Professor, Medicine, Hematology Oncology Division

Emailvicki.villaflor@northwestern.edu

Source: Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Training Experience

2001	Residency, Rush University Medical Center
2004	Fellowship, Rush University Medical Center

Education/Academic qualification

MD, Rush Medical Collage

… → 1998

Fingerprint

Dive into the research topics where Victoria Meucci Villaflor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

9 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished
9 Active

Prot #Ad-p53-002: A Phase 2, Multi-Center, Open Label Study to Evaluate Efficacy and Safety of Adenoviral p53 (Ad-p53) in Combination with Immune Checkpoint Inhibitor Therapy in Patients with Progression or Recurrence of Head and Neck Squamous Cell Carcin
Villaflor, V. M.
MultiVir Inc.
11/22/19 → 11/22/22
Project: Research project
Prot #XB99016/NU 19L01: Phase Ib Study of Brigatinib Plus Bevacizumab in Patients with ALK-rearranged Non-Small Cell Lung Cancer (NSCLC) Who Have Previously Progressed on Prior ALK-Directed Therapy
Villaflor, V. M.
Millennium Pharmaceuticals, Inc
9/16/19 → 9/16/22
Project: Research project
Prot #WO40242: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of Atezolizumab (Anti-PD-L1 Antibody) As Adjuvant Therapy After Definitive Local Therapy In Patients With High-Risk Locally Advanced Squamous Cell Carcinoma Of Th
Villaflor, V. M.
Genentech, Inc.
8/21/19 → 8/21/22
Project: Research project
Prot #HCRN GI17-319/NU UNC19I02: A Single Arm, Multi-Center Phase 2 Trial of mFOLFOX6 + Trastuzumab + Avelumab in First-Line, Metastatic, HER2-Amplified Gastric and Esophageal Adenocarcinomas
Villaflor, V. M.
Hoosier Cancer Research Network, Inc., EMD Serono Research & Development Institute, Inc.
8/12/19 → 8/12/22
Project: Research project
Prot #CACZ885U2301: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study Evaluating the Efficacy and Safety of Pembrolizumab Plus Platinum-Based Doublet Chemotherapy with or without Canakinumab as First Line Therapy for Locally Advanced or Met
Villaflor, V. M.
Novartis Pharmaceuticals Corporation
5/20/19 → 6/1/23
Project: Research project

1698 Citations
43 Article
8 Review article
2 Chapter
2 Comment/debate

The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Oh, M. S., Guzner, A., Wainwright, D. A., Mohindra, N. A., Chae, Y. K., Behdad, A. & Villaflor, V. M., Jan 2021, In: Clinical Lung Cancer. 22, 1, p. e57-e62
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Survivorship support in head and neck cancer: American Head and Neck Society survey
Cognetti, D. M., Villaflor, V. M., Fakhry, C., Miller, M. C. & Malloy, K. M., May 1 2020, In: Head and Neck. 42, 5, p. 939-944 6 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy
Galvez, C., Jacob, S., Finkelman, B. S., Zhao, J., Tegtmeyer, K., Chae, Y. K., Mohindra, N., Salgia, R., Jovanovic, B., Behdad, A. & Villaflor, V., May 26 2020, In: Oncotarget. 11, 21, p. 1953-1960 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti–PD-1/PD-L1 Therapy in Non–Small-Cell Lung Cancer
Chae, Y. K., Davis, A. A., Raparia, K., Agte, S., Pan, A., Mohindra, N., Villaflor, V. & Giles, F. J., Mar 2019, In: Clinical Lung Cancer. 20, 2, p. 88-96.e6
Research output: Contribution to journal › Article › peer-review
22 Scopus citations
Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer
Chae, Y. K., Viveiros, P., Lopes, G., Sukhadia, B., Sheikh, M. M., Saravia, D., Florou, V., Sokol, E. S., Frampton, G. M., Chalmers, Z. R., Ali, S. M., Ross, J. S., Chang, S., Wang, S., Chiec, L., Rahbari, A., Mohindra, N., Villaflor, V., Shin, S. H., Oh, M. & 5 others, Anker, J., Park, L. C., Wang, V., Chuang, J. & Park, W., Oct 2019, In: Journal of Thoracic Oncology. 14, 10, p. 1807-1817 11 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations